The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during [2000] [2001] [2002] [2003] [2004] [2005] . Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.
T hird-generation cephalosporins are drugs of choice for treatment of persons with nontyphoidal Salmonella infections that require chemotherapy or when fl uoroquinolones are contraindicated. A new public health concern is the emergence of third-generation cephalosporin-resistant Salmonella isolates (1) . Multidrug-resistant (MDR) Salmonella enterica serotype Newport isolates that produce CMY-2, a β-lactamase that inactivates third-generation cephalosporins, were fi rst reported in the United States in 1998 (2) . These isolates, known as Newport MDR-AmpC, have quickly spread through the United States in cattle and humans (3) (4) (5) . It has been hypothesized that use of ceftiofur, a third-generation cephalosporin licensed in the United States for use in cattle, could have selected for Newport MDR-AmpC (2-4,7). Several observations and case-control studies suggested beef and milk from dairy cattle were substantial sources of Newport MDR-AmpC infection in humans (6) (7) (8) .
These isolates seem to be extremely rare in Europe. (12) . We undertook the present study to acquire more knowledge on circulation of Newport MDR-AmpC in humans, animals, and animal-derived food in France.
The Study
From Experiments were performed on the 46 third-generation cephalosporin-resistant Newport isolates (additional information available from fxweill@pasteur.fr). All but 1 of the Newport isolates were resistant to cefoxitin (online Appendix Table) . These isolates showed 4 resistance phenotypes; most (41, 89.1%) were resistant to streptomycin, sulfonamides, chloramphenicol, and tetracycline. PCR and sequencing showed that the 45 isolates resistant to cefoxitin were positive for the bla CMY-2 gene, and cefoxitin-susceptible isolates contained the extended-spectrum β-lactamase gene bla CTX-M-1 . Ceftriaxone MICs of Newport MDR-AmpC isolates ranged from 32 mg/L to >256 mg/L, and ceftazidime MICs ranged from 64 mg/L to >256 mg/L. No bla TEM genes were detected. Three isolates with additional resistance to aminoglycosides contained a class 1 integron with the 1-kb gene cassette aadA24 (known to encode resistance to strep- tomycin and spectinomycin) (11) . The chloramphenicol/ fl orfenicol resistance gene fl oR was detected in all but 1 CMY-2-producing Newport isolate. Clonal relatedness of Newport isolates was assessed by multilocus sequence typing (MLST) and PulseNet standard method pulsed-fi eld gel electrophoresis (PFGE) (Figure 1 ). All 16 Newport MDR-AmpC isolates tested had a common sequence type (ST), ST45. XbaI-PFGE identifi ed 10 distinct profi les (similarity 76.7%) among all 45 Newport MDR-AmpC isolates. Single enzyme matches were found for 3 of the profi les (15 isolates) in the US PulseNet national database (www.cdc.gov/pulsenet; online Appendix Table; Figure 2 ). Two PFGE types (New6 and New8) were divided into 2-4 subtypes because of additional band(s) <100 kb. Isolates from the 2003 outbreak showed 4 similar but distinct PFGE profi les that differed by 1-2 bands, migrated between 60 and 100 kb, and were attributed to plasmid(s) (additional information available from fxweill@pasteur. fr). If only cases with indistinguishable PFGE profi les had been tested, potentially related cases would not have been linked to this outbreak. Therefore, during an outbreak investigation of Newport MDR-AmpC, analysis of plasmid content (either by alkaline lysis or S1 nuclease, depending on size of additional bands) might complete XbaI-PFGE profi les for isolates whose profi les differ by 1 or 2 additional bands of low molecular mass.
Alkaline lysis extraction showed that all but 1 of the Newport MDR-AmpC isolates harbored a plasmid >125 kb that hybridized with a bla CMY-2 probe; the remaining isolate harbored a plasmid of 100 kb (online Appendix Table) . Analysis with S1 nuclease showed that these plasmids were 100 kb-370 kb. Up to 3 additional plasmids (3.5 kb-100 kb) that did not have bla CMY-2 were detected in most isolates (online Appendix Table) . Cephalosporin resistance was transferred by electroporation of plasmid DNA to Eschericha coli DH10B for all 38 CMY-2-positive isolates tested. When present in the donor strain, resistance to sulfonamides, chloramphenicol, and tetracycline was also transferred. Restriction analysis of plasmids isolated from transformants showed 6 similar restriction profi les for Newport isolates (R1-R6) (Figure 2 , online Appendix Table) . R1 was predominant (found in 26 isolates among 35 tested, 74.3%). Newport plasmids R1-R6 and Agona plasmid R8 were shown by PCR to contain variant A/C 2 replicons (13), whereas Typhimurium plasmid R7 contained the I1 replicon.
PstI-digested plasmids analyzed by Southern hybridization with a bla CMY-2 probe (Figure 2 ) showed 4 hybridization profi les among Newport isolates. Profi le H1 corresponded to plasmid type C described by Carattoli et al. (14) . Profi les H2, H3, and H4 differed from H1 by 1 additional band (>10 kb for H2, 3.2 kb for H3, and >18 kb for H4), which indicated that the bla CMY-2 gene was partially or totally duplicated.
Conclusions
Newport mids carrying bla CMY-2 were homogeneous (same incompatibility group A/C 2 , a main restriction type R1, and a main hybridization type H1). These results support clonal expansion of 1 Newport strain (or a limited number of genetically related Newport strains) able to acquire and maintain a large incA/C 2 MDR plasmid.
The source of the French isolates remains unknown. However, this strain was not found in French food animals or domestically produced food products (additional information available from fxweill@pasteur.fr). One outbreak during the study period was linked to imported horse meat. Further investigation identifi ed the source as a wholesaler who imported meat from Belgium, the United Kingdom, Hungary, Canada, Brazil, Argentina, Uruguay, and Australia (12) . In contrast to Europe, Newport MDR-AmpC has been frequently seen in the United States during the past decade. Furthermore, several characteristics were shared between US and French Newport MDR-AmpC isolates: ST45 (15), PFGE profi les New5, New6a, and New6b (displayed by 15 isolates among the 45 studied), and bla CMY-2 plasmid hybridization type H1 (14 
